Veracyte to Present Six Genomic-Test Studies at ESMO 2026
Veracyte says the studies include new Decipher treatment-selection evidence and an OPTIMA breast cancer health economic analysis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Veracyte to present six genomic test studies at ESMO 2026
The studies will cover breast, prostate and bladder cancer.